NASDAQ: OKUR
OnKure Therapeutics, Inc.
Healthcare · Biotechnology
After hours: $4.14(0%) · as of 7:34 PM ET
Market Cap
$56.61M
52w High
$5.38
52w Low
$1.91
P/E
-1.18
Volume
79.57K
Outstanding Shares
13.67M
Price vs Fundamentals
Why The Stock Is Moving
What changed
The stock rose 105.97% over the last year. Free cash flow grew 18.95% over the trailing twelve months.
What the market seems to be pricing
The stock move broadly lines up with stronger business momentum. The operating data is doing enough work that the move does not need an overvaluation story to explain it.
What would invalidate this read
If revenue growth, margins, or free cash flow roll over while the stock keeps climbing, more of the move would be coming from multiple expansion than business progress.
Company profile
OnKure, Inc., established in 2011 and based in Boulder, Colorado, operates as a biopharmaceutical company primarily engaged in the creation and advancement of precise therapeutic agents for cancer.
Valuation
Stock splits
Every 10 shares became 1
Profitability & growth
Analyst consensus
2
Buy
0
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Nov 5, 2026
Q4 FY26 · EPS est -$0.51 · Revenue est $166.67K
View